HomeCompareCDNS vs HRC

CDNS vs HRC: Dividend Comparison 2026

CDNS yields 0.74% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRC wins by $2.24M in total portfolio value
10 years
CDNS
CDNS
● Live price
0.74%
Share price
$270.88
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.7K
Annual income
$77.46
Full CDNS calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — CDNS vs HRC

📍 HRC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDNSHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDNS + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDNS pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDNS
Annual income on $10K today (after 15% tax)
$62.76/yr
After 10yr DRIP, annual income (after tax)
$65.84/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, HRC beats the other by $1,209,849.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDNS + HRC for your $10,000?

CDNS: 50%HRC: 50%
100% HRC50/50100% CDNS
Portfolio after 10yr
$1.14M
Annual income
$711,753.55/yr
Blended yield
62.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CDNS right now

CDNS
Analyst Ratings
25
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$377.88
+39.5% upside vs current
Range: $275.00 — $418.00
Altman Z
10.9
Piotroski
6/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDNS buys
9
HRC buys
0
PoliticianChamberTickerTypeAmountDate
Michael McCaul🏢 House$CDNS▼ Sell$1,001 - $15,0002025-10-27
Val Hoyle🏢 House$CDNS▼ Sell$1,001 - $15,0002025-09-23
Ro Khanna🏢 House$CDNS▲ Buy$1,001 - $15,0002025-08-26
Gilbert Cisneros🏢 House$CDNS▼ Sell$1,001 - $15,0002025-08-05
Michael McCaul🏢 House$CDNS▼ Sell$15,001 - $50,0002025-06-16
Jefferson Shreve🏢 House$CDNS▼ Sell$50,001 - $100,0002025-05-12
Greg Landsman🏢 House$CDNS▼ Sell$1,001 - $15,0002025-03-27
Rob Bresnahan🏢 House$CDNS▲ Buy$1,001 - $15,0002025-03-17
Gilbert Cisneros🏢 House$CDNS▼ Sell$1,001 - $15,0002025-02-26
Rob Bresnahan🏢 House$CDNS▼ Sell$1,001 - $15,0002025-01-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDNSHRC
Forward yield0.74%11.38%
Annual dividend / share$2.00$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.3%
Portfolio after 10y$20.7K$2.26M
Annual income after 10y$77.46$1,423,429.65
Total dividends collected$758.00$2.14M
Payment frequencyquarterlyquarterly
SectorTechnologyStock
Analyst consensusBuyHold

Year-by-year: CDNS vs HRC ($10,000, DRIP)

YearCDNS PortfolioCDNS Income/yrHRC PortfolioHRC Income/yrGap
1← crossover$10,774$73.83$12,296$1,595.93$1.5KHRC
2$11,602$74.34$15,730$2,573.05$4.1KHRC
3$12,489$74.82$21,147$4,316.00$8.7KHRC
4$13,439$75.27$30,235$7,608.15$16.8KHRC
5$14,455$75.70$46,615$14,263.36$32.2KHRC
6$15,543$76.10$78,712$28,834.27$63.2KHRC
7$16,708$76.47$148,063$63,841.01$131.4KHRC
8$17,954$76.82$315,890$157,462.80$297.9KHRC
9$19,288$77.15$778,498$440,495.17$759.2KHRC
10$20,716$77.46$2,256,422$1,423,429.65$2.24MHRC

CDNS vs HRC: Complete Analysis 2026

CDNSTechnology

Cadence Design Systems, Inc. provides software, hardware, services, and reusable integrated circuit (IC) design blocks worldwide. The company offers functional verification services, including emulation and prototyping hardware. Its functional verification offering consists of JasperGold, a formal verification platform; Xcelium, a parallel logic simulation platform; Palladium, an enterprise emulation platform; and Protium, a prototyping platform for chip verification. The company also provides digital IC design and sign off products, including Genus logic synthesis and Joules RTL power solutions, as well as Modus software solution to reduce systems-on-chip design-for-test time; physical implementation tools, such as place and route, optimization, and multiple patterning preparation; and signoff products to signoff the design as ready for silicon manufacturing. In addition, it offers custom IC design and simulation products to create schematic and physical representations of circuits down to the transistor level for analog, mixed-signal, custom digital, memory, and radio frequency designs; and system design and analysis products to develop printed circuit boards and IC packages, as well as to analyze electromagnetic, electro-thermal, and other multi-physics effects. Further, the company provides intellectual property (IP) products comprising pre-verified and customizable functional blocks to integrate into customer's ICs; and verification IP and memory models to emulate and model the expected behavior and interaction of standard industry system interface protocols. Additionally, it offers services related to methodology, education, and hosted design solutions, as well as technical support and maintenance services. The company serves 5G communications, aerospace and defense, automotive, industrial and healthcare, mobile, consumer, and hyperscale computing markets. Cadence Design Systems, Inc. was incorporated in 1987 and is headquartered in San Jose, California.

Full CDNS Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this CDNS vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDNS vs SCHDCDNS vs JEPICDNS vs OCDNS vs KOCDNS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.